Evidence map›Paper›PMID 32822833›Full record

ReviewClinical immunology (Orlando, Fla.)2022

Effects of dietary restriction on gut microbiota and CNS autoimmunity.

Claudia Cantoni, Yair Dorsett, Luigi Fontana, Yanjiao Zhou, Laura Piccio

Open access · greenAbstract readReview
In one paragraph

Review in Clinical immunology (Orlando, Fla.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Multiple sclerosis: molecular pathogenesis and therapeutic intervention.Signal transduction and targeted therapy · 2025
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Claudia CantoniDepartment of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Yair DorsettDepartment of Medicine, University of Connecticut Health Center, Farmington, CT 06032, USA.
Luigi FontanaCharles Perkins Center, Faculty of Medicine and Health, University of Sydney, NSW 2006, Australia; Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, NSW 2006, Australia; Department of Clinical and Experimental Sciences, Brescia University School of Medicine, Brescia, Italy.
Yanjiao ZhouDepartment of Medicine, University of Connecticut Health Center, Farmington, CT 06032, USA.
Laura PiccioDepartment of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA; Brain and Mind Centre, University of Sydney, Sydney, NSW 2050, Australia. Electronic address: laura.piccio@sydney.edu.au.
UConn Health · USUniversity of Sydney · AUWashington University in St. Louis · US

Funding

Intermittent Fasting-induced Gut Microbiome Modulation of CNS AutoimmunityR01NS102633 · NINDS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI ZHOU, YANJIAO · 2017 to 2022
$2.1M
NINDS NIH HHS R01 NS102633
6 · The paper itself

Abstract

Multiple sclerosis (MS) is the most common central nervous system (CNS) autoimmune disease. It is due to the interplay of genetic and environmental factors. Current opinion is that diet could play a pathogenic role in disease onset and development. Dietary restriction (DR) without malnutrition markedly improves health and increases lifespan in multiple model organisms. DR regimens that utilize continuous or intermittent food restriction can induce anti-inflammatory, immuno-modulatory and neuroendocrine adaptations promoting health. These adaptations exert neuroprotective effects in the main MS animal model, experimental autoimmune encephalomyelitis (EAE). This review summarizes the current knowledge on DR-induced changes in gut microbial composition and metabolite production and its impact on underlying functional mechanisms. Studies demonstrating the protective effects of DR regimens on EAE and people with MS are also presented. This is a rapidly developing research field with important clinical implications for personalized dietary interventions in MS prevention and treatment.

Indexed as

Caloric RestrictionFastingAnimalsGastrointestinal MicrobiomeHumansObesity

Identifiers

PMID32822833
PMCPMC7889763
OpenAlexW3052717662

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.